Related Experiment Videos
High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease
Robert S Rosenson1, Wolfgang Koenig
1Preventive Cardiology Center, Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611, USA. r-rosenson@northwestern.edu
Insights
High-sensitivity C-reactive protein (hs-CRP) is a reliable inflammatory marker that predicts cardiovascular events in coronary heart disease patients. Reducing hs-CRP may lower cardiovascular risk.
Area of Science:
- Cardiology
- Inflammation
- Biomarkers
Background:
- High-sensitivity C-reactive protein (hs-CRP) is increasingly recognized for its role in cardiovascular disease.
- Prospective studies link elevated hs-CRP to increased risk of initial and recurrent cardiovascular events.
- Unlike other markers, hs-CRP measurements are standardized and reproducible, enhancing clinical utility.
Purpose of the Study:
- To review the significance of hs-CRP in cardiovascular risk stratification for coronary heart disease (CHD) patients.
- To discuss preventive therapies targeting hs-CRP reduction for improved cardiovascular outcomes.
Main Methods:
- Literature review of prospective studies on hs-CRP and cardiovascular events.
- Analysis of the clinical significance and applications of hs-CRP as an inflammatory marker.
- Examination of therapeutic strategies aimed at reducing hs-CRP levels.
Main Results:
- High hs-CRP levels are strong predictors of cardiovascular events in various CHD patient groups.
- hs-CRP serves as a reliable tool for identifying high-risk individuals and monitoring disease activity.
- Standardized hs-CRP assays ensure reproducibility and clinical reliability.
Conclusions:
- hs-CRP is a crucial biomarker for cardiovascular risk stratification in coronary heart disease.
- Targeting inflammation through hs-CRP reduction represents a potential therapeutic strategy for cardiovascular prevention.
Abstract:
High-sensitivity C-reactive protein levels have received widespread attention because of a multitude of prospective studies that have shown that high levels of high-sensitivity C-reactive protein identify increased risk of initial cardiovascular events in coronary heart disease patients and increased risk of recurrent cardiac events in patients with stable and unstable angina, patients with acute myocardial infarction, and patients undergoing elective coronary revascularization procedures. In contrast to several other inflammatory markers, high-sensitivity C-reactive protein measurements are standardized and reproducible. The clinical significance of a reliable inflammatory marker includes identification of high-risk individuals, a gauge to monitor the activity of the disease, and a potential therapeutic target to alter the inflammatory component of the disease process. This review focuses on the importance of high-sensitivity C-reactive protein in cardiovascular risk stratification in coronary heart disease patients and discusses several preventive therapies that may reduce cardiovascular risk through reduction in high-sensitivity C-reactive protein.